Intellia Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
13.04.23
/
50%
€33.50
Target price
13.04.24
€59.72
Performance (%)
-29.85%
End price
14.04.24
€23.50
Summary
This prediction ended on 14.04.24 with a price of €23.50. The prediction for Intellia Therapeutics Inc disappointed with a performance of -29.85%. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Intellia Therapeutics Inc | 5.756% | 5.756% | -40.154% |
iShares Core DAX® | -0.051% | 4.829% | 17.062% |
iShares Nasdaq 100 | 1.659% | 2.417% | 38.705% |
iShares Nikkei 225® | 0.658% | -2.173% | 13.159% |
iShares S&P 500 | 0.964% | 2.547% | 30.492% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $66.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten